Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Benjamin Sexton

Physician Assistant, Medical Fayetteville, AR Physician Assistant

NPI 1982905444 CMS profile 10728185

2523 E Huntsville Rd, Fayetteville, AR 72701

Open in the dashboard

General payments

$2,650

169 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Benjamin Sexton of Fayetteville, AR is reported in the CMS Open Payments database as having received $2,650 across 169 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $479 27
2024 General $731 50
2023 General $511 31
2022 General $557 36
2021 General $372 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Sexton
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Benjamin Sexton were reported at $479. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Benjamin Sexton Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $372 $156 $41–$563 $132
2022 $557 $185 $55–$649 $149
2023 $511 $199 $58–$717 $160
2024 $731 $206 $62–$740 $164
2025 $479 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $403 20 payments
  2. Pfizer Inc. $377 29 payments
  3. Novo Nordisk Inc $260 18 payments
  4. Lilly USA, LLC $214 14 payments
  5. Abbott Laboratories $212 13 payments
  6. Amgen Inc. $162 10 payments
  7. Merck Sharp & Dohme Corporation $126 8 payments
  8. Phathom Pharmaceuticals, Inc. $96 6 payments
  9. GlaxoSmithKline, LLC. $92 6 payments
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $72 5 payments
  11. Other $635 40 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,650 169 payments
Products named General payments · program years 2021–2025
  1. QULIPTA $198 10 payments
  2. NURTEC ODT $193 17 payments
  3. Ozempic $191 13 payments
  4. ZAVZPRET $177 16 payments
  5. RYBELSUS $176 12 payments
  6. FreeStyle Libre $172 11 payments
  7. COMIRNATY $170 11 payments
  8. PREVNAR 20 $169 11 payments
  9. VRAYLAR $148 7 payments
  10. Repatha $146 9 payments
  11. Other $2,286 145 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

331

Median for Physician Assistant: 241

Drug cost

$6,816

Median for Physician Assistant: $4,110

Branded share of claims

45.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Paxlovid Nirmatrelvir/Ritonavir Brand 22 $4,218
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 63 $568
Doxycycline Hyclate Generic 38 $423
Albuterol Sulfate Hfa Albuterol Sulfate Brand 16 $366
Methylprednisolone Generic 36 $258
Cefdinir Generic 16 $253
Cefuroxime Cefuroxime Axetil Brand 21 $233
Azithromycin Generic 40 $185
Cephalexin Generic 16 $92
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 18 $82

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$27,835

Of which drugs: $7,248

Medicare patients

316

Average age 74

Services billed

5,051

203 women, 113 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 43%
Ischemic heart disease 26%
Depression 25%
Diabetes 23%
Chronic kidney disease 17%
Atrial fibrillation 16%
Osteoporosis 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Vaccine for influenza for injection into muscle 90662 Office 37 37 $3,017
Sarscv2 vac 30mcg trs-suc im 91320 Office 17 17 $2,573
Injection, methylprednisolone acetate, 1 mg J1010 Office 38 3,720 $359
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 44 184 $15

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 25 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VOQUEZNA
  • Phathom Pharmaceuticals, Inc. $78
$78 — —
NURTEC ODT
  • PFIZER INC. $75
$75 — —
ZAVZPRET
  • PFIZER INC. $75
$75 — —
QULIPTA
  • AbbVie, Inc. $51
$51 — —
ZEPBOUND
  • Lilly USA, LLC $37
$37 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 25 in the dashboard with a free account

Records

169 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Arkansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record